The vaccine from the AstraZeneca laboratory was created in collaboration with the University of Oxford.
SOPA Images / SIPA
The British Medicines Agency (MHRA) has given the green light to the anti-Covid vaccine developed by the British group AstraZeneca with the University of Oxford, with which the authorities intend to accelerate the vaccination campaign launched in early December.
The UK is the first country to approve this cheaper, easier to distribute vaccine.
The green light "follows rigorous clinical trials and extensive data analysis by experts from the MHRA, which concluded that the vaccine met its strict standards for safety, quality and efficacy," explained the spokesperson for the Ministry of Health in a press release.
The UK has ordered 100 million doses of the vaccine, on contracts totaling more than 350 million doses by the end of next year, sourcing from seven manufacturers in the early stages. clinical tests.
600,000 vaccinated in the UK in less than a month
It is the second vaccine approved by the MHRA, after that of Pfizer / BioNTech inoculated to more than 600,000 people since December 8.
That of AstraZeneca and Oxford is eagerly awaited for practical reasons.
It is much less expensive than the one already distributed and can be stored in conventional freezers without the need for storage at -70 degrees.
One of the countries most affected in Europe by the pandemic with more than 71,000 dead, the United Kingdom is facing a surge in contaminations attributed to a variant of the virus, presenting according to a British study a contagiousness greater than 50% to 74 %.
This phenomenon has prompted the authorities to reconfigure a large part of the population (40% of the population in England, mainland Scotland, Wales and Northern Ireland).
AstraZeneca says it has 'winning formula' for vaccine ahead of UK decision
AstraZeneca laboratory and Russia want to combine their vaccines